|
|
VITAL: Paricalcitol reduced renal, CV risks in patients with diabetic nephropathy - Endocrine Today |
|
Endocrine TodayAdding 2 mcg per day of paricalcitol to renin-angiotension-aldosterone system inhibition appears to be a novel approach to lower residual renal risk for ... |
|
|
NIH videos help health providers answer questions about dialysis - National Institutes of Health (press release) |
|
National Institutes of Health (press release)Health care providers can now take advantage of a new video series to help them talk with patients about preparing for dialysis treatments, the National ... |
|
Barangay health service providers undergo REDCOP orientation-workshop - Philippine Information Agency |
|
Philippine Information AgencyESRD is a condition where both kidneys are completely and irreversibly damaged, commonly caused by diabetic Nephropathy, chronic Glomerulonephritis and ... |
|
Medication adherence may enhance blood pressure control in chronic kidney disease - HealthJockey.com |
|
HealthJockey.comCharuhas Thakar, MD, associate professor in the division of nephrology and hypertension at UC and chief of the renal section at the Cincinnati VA, alleged,
|
|
NxStage® Expands Product Portfolio With Innovative Patient Access Surveillance ... - Sacramento Bee |
|
Sacramento BeeWeekly reports that identify at-risk patients are issued to the dialysis provider and allow the dialysis staff to proactively schedule further testing on ...NXSTAGE MED : NxStage® Reports Record Third Quarter 2010 Financial Results and ... |
|
|
|
|
<< Start < Prev 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 Next > End >>
|
|
Page 1238 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
